Q: Trying to wrap my mind around Well. It’s current financial status and future potential. Are you able to outline balance sheet, cash flow, profitability, growth and upside potential etc. Isn’t this a good sector to be in during these times? It looks significantly discounted from where it was. What are the risks. Thx.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
-
Amgen Inc. (AMGN)
-
AbbVie Inc. (ABBV)
-
Eli Lilly and Company (LLY)
-
Pfizer Inc. (PFE)
-
iShares Global Healthcare ETF (IXJ)
-
Health Care Select Sector SPDR (XLV)
Q: Hi Peter,
I don't have any positions in the Health Care sector. Please provide a few suggestions, either stocks and/or ETFs, for both Canada and USA. I would like the Buy and Hold for say 5 years or more strategy.
Many thanks,
Roger
I don't have any positions in the Health Care sector. Please provide a few suggestions, either stocks and/or ETFs, for both Canada and USA. I would like the Buy and Hold for say 5 years or more strategy.
Many thanks,
Roger
Q: GH I read the results and don't follow the reasoning for the huge drop today. Would appreciate your views as in Buy, sell or hold now.
John
John
Q: Season's greetings - what are your thoughts on MRNA. The skin cancer test results lofted the shares yesterday. It still seems inexpensive, given a sub six PE. I have a small holding and am thinking of investing more. It's well within my portfolio recommendations. Don't understand why it not getting more love with all the viruses running around the world. Thanks
Q: What are your thoughts on MPW and the sustainability of its current dividend? I own a small position and am tempted to buy more. Thanks
al
al
Q: would you recommend buying more & selling other stocks
ecn,
ecn,
Q: Why is this company down almost 5% today? Any news?
Thanks
Thanks
Q: is there any hope after latest drop.The company has been quiet
-
Vanguard FTSE Emerging Markets All Cap Index ETF (VEE)
-
iShares Biotechnology ETF (IBB)
-
INVESCO QQQ Trust (QQQ)
-
Vanguard Information Technology ETF (VGT)
-
iShares U.S. Healthcare ETF (IYH)
Q: Further to your response to Tom on Dec. 5th, could you recommend several ETFs that would be quality choices to represent emerging markets, healthcare and tech that would result in less overall volatility than purchasing individual stocks? Thanks.
Q: Hello 5i, Could you comment on Profound Medical PRN and also the spike in the price today.
Q: Given the choice of a health care stock to add for portfolio diversification, which of CVS or LLY would you recommend and why. Thanks
-
Stryker Corporation (SYK)
-
Health Care Select Sector SPDR (XLV)
-
iShares U.S. Medical Devices ETF (IHI)
-
Smith & Nephew SNATS Inc. (SNN)
Q: Hi
I am down quite a bit on SNN? I am temped to sell for a tax loss and replace with xlv or IHI but am concerned that xlv or ihi as etfs do not have the same bounce potential as snn. is there another healthcare stock you can recommend or would you replace with xlv or ihi?
thanks
I am down quite a bit on SNN? I am temped to sell for a tax loss and replace with xlv or IHI but am concerned that xlv or ihi as etfs do not have the same bounce potential as snn. is there another healthcare stock you can recommend or would you replace with xlv or ihi?
thanks
Q: LIFE,DHT.For income would you have a preference,both or neither?Thanks.
Q: Can you give your opinion on Zymeworks, please. It's been awhile and this company has made some links with big players. Thanks for your excellent service.
Q: Question about Veeva Systems.
From prior responses, it aligned with right now having a high valuation even after the past years negative performance. Is this a good entry point? This has been on my watchlist for years now and each time I look at it, the valuation is too expensive. But with the recent drop is this a good entry point or do you think the market is signalling that growth is slowing down?
From prior responses, it aligned with right now having a high valuation even after the past years negative performance. Is this a good entry point? This has been on my watchlist for years now and each time I look at it, the valuation is too expensive. But with the recent drop is this a good entry point or do you think the market is signalling that growth is slowing down?
Q: I bought some medical start-ups in private placements around 2004 through 2007, including TMD Titan Medical. I bought into the both the Canadian and the US private placements. TMD has had a number of frustrating round-trips. Yesterday December 5, TMD stock saw considerable action both sides of border: opened yesterday at 0.90 Canadian , went up 40% to 1.25 closing the day at C$1.15 on high volume. Collapsed this morning. I see no news to explain the swing. The company sent shareholders anote about a strategic review. Perhaps a takeover is in the wings? Do you have any news on TMD? Would you hold or sell? (Tax loss not useable).
Q: These are all huge losers for me. Is it worth keeping all of them, or lightening up? If so what would you let go?
John
John
Q: Would appreciate your views on Canopy.
Q: Is todays drop on LNTH anything to worry about or a buying opportunity?
Thanks for your service!
Thanks for your service!
Q: With the Horizon announcement that there are 2 (named) possible acquirers (by Jan.23/23), would you wait or, after the recent jump, take the money and run?